2025-03-31-accounts

The ELF Office Haematology Centre Royal Devon & Exeter Hospital Barrack Road Exeter EX2 5DW Charity Number 1154727 exetef leukaemia fund l October 2025 Dear Sirs This representation letter Is provlded In connectlon with independent examination of the flnancial statements of the charity for the period ended 31 March 2025, for the purpose of expressing an opinion as to whether the financial statements are presented fairly, In al I materlal aspects, lor give a true and fa ir view) in accordance with the applicable financial reportlng framework. We confirm that the following representations are made on the basls of enquiries of the trustees, management and staff with relevant knowledge and experience {and, where appropriate, of inspection of supporting documentation) suff icient to satisfy ourselves that we can properly make each of the following representations to you: l. We have fulfi Iled our responsibilitles as trustees under the Charities Act 2011 for preparing financial statements, in accordance with the applicable financial reporting framework, FRS 102 and the FRS 102 Charity SORP. We confirm that in our opinion the flnanclal statements give a true and fair view and in partlcular that where any additional information must be disclosed in order to give a true and fair view that Informatlon has In fact been disclosed, We confirm that the selectlon and application of the accounting pollcles used in the preparation of the financial statements are appropriate, and we approve these accounts for the period ended 31 March 2025. 2. We confirm that all accounting records have been made available to you for the purpose of the independent examination, in accordance with your terms of engagement, and that all the transactions undertaken by the charity have been properly reflected and recorded in the accounting records. All other records and related information, includi ng minutes of all Management, trustees, and members, meetings, have been made available to you. We have given you unrestricted acces5 to persons within the charity in order to obtain evidence and have provided any additional information that you have requested for the purposes of the Independent examination. 3. We confirm the charity has satisfactory title to all assets and there are no liens or encumbrances on the assets, except for those disclosed in the financial statements. 4. We confirm that significant assumptions used by us in making accounting estimates, including those measured at fair value, are reasonable. S. We confirm that we have no plans or intentions that may materially alter the carrying value and, where relevant, the fair value measurements or classification of assets and liabilities reflected in the financial statements. Registered CIO 1154727 www.elfcharity.org.uk

1. We confirm that the charity has no liabilities or contingent liabilities other than those disclosed in the financial statements.
2. We confirm that all known actual or possible litigation and claims whose effects should be considered when preparing the financial statements have been disclosed to you and accounted for and disclosed in accordance with the applicable financial reporting framework.
3. We confirm that there have been no events since the balance sheet date which requlre dlsc1051ng or which would materially affect the amounts in the financial statements, other than those already disclosed or included i n the financial statements,
4. We confirm that we are aware of the definition of a related party for the purpose of the accounting framework being applied in the preparation of the accounts, We confirm that there have been no materia I transactions with related parties.
5. We confirm that the charity neither had, at any tlme during the year, any arrangement, transaction or agreement to provide credit facillties lincludi n8 advances and credits granted by the charity) for trustees, nor provided guarantees of any kind on behalf of the trustees.
6. We confirm that the charity has not contracted for any capital expendlture,
7. We confirm that the charity has complled wlth all aspects of contractual agreements that could have a material effect on the financial statements in the event of non-compliance.
8. We confirm that we are not aware of any possible or actual Instance of non-compliance with those laws and regulations which provide a legal framework within which the charity conducts its activities and which a re central to the charitvs a bility to conduct Its activities.
9. We acknowledge our responsibility for the design, implementation and maintenance of internal controls to prevent and detect fraud.
10. We confirm that there have been no actual or suspected instances of fraud involving trustees, management or employees who have a significant role In Internal control or that could have a material effect on the flnanclal statements. We also confirm that we are not aware of any allegations of fraud by trustees, former trustees, analysts, employees, former employees, regulators or others.
11. We confirm that, in our opinion, the charit¢s flnancial statements should be prepared on the golng concern basis on the grounds that current and future sources of funding or support will be more than adequate for the charity's needs. In reaching this conclusion, we have taken into account all relevant matters of which we are aware, and have considered a period of at least one year from the date on which the financial statements will be approved.
12. We confirm that all grants, donation5 and other income, including those subject to special terms or conditions or received for restricted purposes, have been notified to you. There have been no breaches of terms or conditions during the period regarding the application of such income.
13. We confirm that in our opinion the effects of unadjusted misstatements are immaterial, both individually and In aggregate, to the financial statements as a whole.
14. We confirm the following specific representations made to you durlng the course of your independent examination:. a. We confirm that funds have been correctly designated as restricted where those funds can only be lawfully used for a specific charitable purpose5 which are narrower than the general purposes of the charity. Registered CIO 1154727 www.elfcharity.org.uk

b. We confirm that all income streams have been reviewed and assessed in terms of VAT compliance. We also confirm that there are no income streams which are deemed to be taxable. 20. We acknowledge our legal responsibilities regarding disclosure of information to you as independent examiners and confirm that: so far as each trustee 15 aware, there is no relevant Information of which you as independent examiner5 are unaware,. and each trustee has taken all the steps that they ought to have taken as a trustee to make themselves aware of any relevant information and to establish that you are aware of that information. Yours faithfull Signed on be alf the boa stees Trustee Date.......... Registered CIO 1154727 www.elfcharity.org.uk

Charity registsation iiumber. 1154727 Exeter Leukaemia Fund CIO Annual Report Mt)d Financial Statements for the Year Ended 31 March 2025

Exeter Leukaemia Fund CIO Contents (continued) Reference and Administrative Details Trustees, Report 2to9 Statement of Trustees, Responsibilities 10 Independent Examiner's Report Statement of Financial Activities 12to 13 Balance Sheet 14 Notes to the FinanciAI Statemeiits 15tD26

Exeter Leukaemia Fund CIO Reference and Administrative Details Chairman V E S Salomonsen Trustees V E 5 Salomonsen l M Kenny CFOX J M Hawkins Sscann S R Cooper D Charlesworth Senioi. MHn¥gement l Leadership M Soutliwood. Chief Exewtive Officer Team ChArity R¢gistratioM Number 11547?7 Principal Office The ELF Office Haematology C.entre Royal Devon & Exeter Hospital Bai'rack Road Exeter EX2 5DW Independent Examlner Thompson Jenner LLP Independent Examinei. I Collcton Crescent Exeter Devon EX2 4DG Solicitors Tozers Solicitors LLP Broadwalk House Southernhay West Barclays Bank PLC 3 Bedford Street Exeter Devon Bgnkers EXI ILX Santander UK PLC 53 High Street Exeter Devon EX4 3HE Page I

Exeter LeukAemia Fund CIO Trustees, Report The trustee5 present the annual report together with the financial stateinents of the charity for the yeai. ended 31 March 2025. Trustees and officers The truslees and officers setwing during the year since the year end were as follows.. Trustees: V E S Salomonsei) l M Kenny CFOX J M Hawkins Ssconn S R Cooper D Charl¢sworth (appointed 5 December 20?4) Chairman.. V E S Salonionsen Senior Management / Leadership Teain.. M Southwood, Chief Execulive Officer S Peacock, Head of Operations and Finance (resigned 21 June 2024) Chief Executive Officer's Statement The 2024125 year was a good one for ELF. It remains a pleasure and privilege to lead a great teaiii, and to watch the charity go froin sli'ength to strcngth. Across t11e yeai.. we supported more patieiits aiid families tl)an evei. before, travelling across the county to bring patients lo appointinents, serving Inue17-n¢eded refreshments in the waitiiig room. and increasin¥ oui. wellbeing service. Additionally, ELF streiigtheiied liiiks with both the NHS team and Citizens Advice, conliiiLiiiig to work towards a joiiied-up offering. Our Fellowsliip Pi'ogramme, launched the previous year. contirtiied to provide ￿ndS to liaeniatology staff to undertake furLher study. As well a5 several Fellowships awarded foi. staft. including nurses and Inedical students to attend confereii¢es, we were also delighted to offer a larger grant to Jade. an Apprentice Nurse. to complete her nursing degree. Our staff team grew in the last qUElrter of the year, as we welcomed a new adiministrator and fundraiser to help support our growth ambitions. We also welcomed a new Trustee. the first in over two years. We are proud to be a 511iall, local charity supporting families who we ofteii conie to know very well. Aniong those we supported across the year was Mr P., who lived alone and faced a termiiial diagnosis. Over the month5 of his treMtmenL our tran5POrt te&m got to know Mr P, and during his journeys to and fi'om hospital, provided companionship and comfort. Mr P sadly passed away in aU￿￿n 2024, but remeniber¢d ELF in his Will, a generous acknowledgement ofhow important ELF'S services are to 50 many. In the final quarter of Éhe year. we signed an Agreement for Lease on a new office premises, a tangible step towai'ds furthei. growth. Exeter Leukaeinia Fund continues to gl'ow and thrive, and we look forward to supporting more families. Molly Southwood Chief Executive Officer Page 2

Exeter Leukaemia Fund CIO Trustees, Report (continued) Objective5 And activities Policies and objeetives The objectives of ELF, which are oiitlined in the Constitution of the CIO dated l January 2014 are.. To promote and protect the physical and mental health of people suffering from leukaemia and related diseases iii the South West of Englaiid (and parLicularly those living iii Devon). and their relatives and loved ones. through the provision of fiiian¢ial assistance, support, specialist equipmeiit, education and practical advice. whether to those people or to hospitals, ¢lini¢s and hospices in Devon and neighbouring ¢ounties. To advance tPte ediication of the public in all areas relating lo Leulcaemia and relatcd diseases. In settino objectives and planning for activities, the Trustees aiid senior management have given due consideratioii to geiieral guidance published by the Charity Commission relating to public benefit. includiiig the guidance 'Piibli¢ benefit: running a charity (PB2)'. Vlsion, Mission and Strat¢gy Vision We want every patient in Devon diagnosed with blood cancer to have the bcst possible outcome. Mission Statement ELF'S niission is to Ci'eate an envii'onment where patients and t17eir famili¢s ure supported through their leukaemia journey. We want to ensure all blood cancer patients and their families have access to exLellent support Services, from the poiiit of diagnosis to recovery and beyond. Strategy Workiiig with our partners in the NHS, we will design and delivei. 5ector-leading services (o offer direct support to patients aiid support ihe Haeinatology Centre at the Royal Devon & Exeter Hospital. wliich we helped to build. Strategic Objectives Each y¢ar, tlie Boai-d of Trustees works together with the senior leadership team to agree strategic obje¢tives for thc coming year, and beyond. Ow. strategic objectives for the 2024125 year were.. l. Service Dev¢lopinent .Increase Qu￿ent service delivery b. Nortji Devon and sites othei. tlian RDE Wellbeing Services 2. Preparing for futL￿e srowth a. Marketing aiid brand awareness b. Income generation, in particular legacies and grants 3. New Homelliub search and planning 4. f501ation Room Refurbishment Page 3

Exeter Leukaemia Fund CIO Trustees, Report (continued) Seryice Development The table below gives an overview of our performance against our targets. Servlce 24125 Target 25 Actual ounselling Referrals 110 111 ransport Total Patients 160 179 upport Group Attendance Patient Grants 20 241£12,000 mplementary Therapy Patients ccommodation Patients 150 10 Citizens, Advice Referrals 11 S•rvlce Users 76 Overall. the i)umber of patients we supported iiicreased fi'oni th¢ previous year. W¢ also improved Imany processes to ensure better d&la capiure and impact reportiiig. We impi'oved our links with our NHS colleagues in North Devon and subsequently saw an increase in requests for our services from that part ot the county. We also ints'oduced a sei'ies of support groups. with tlie intention of reaching a broader range of patients than we did with couiiselling alone. The first series, a patient group, was developed in collaboration with the NHS haematology teaiii. The second series, ruli indepeiidently by ELF, focused on faniily meinbers aiid supporters. Preparing for Future Growth The Board of Trustees recognises that increasing the number of patients and families supported by ELF will result in increased costs. To put us in tile best possible position lo fuiid that gr0￿h, the charity appointed two new members of staff in 2024, with a view to increasing philanthropic income by arouiid £150.000 eacli year. Tlie team also worked to improve ELF'S visibility iii Ihc local community. and oreate a better understanding of the charity's impact. By focusing on sevei'al high-pix)file 'Charity of Year, initiative, including the Princesshay Shopping CenÉre iii Exeler. tlie team were able to raise local awareness. Iiivestineiit was also made iii improving impact communications, iticluding press releases sent to the local niedia and advert15iiig campaigiis around tlig local area. Page 4

Exeter Leukaemia Fund CIO Trustees, Report (continued) New HomelHub Tn planning me¢tings, the need for a'hub" where office-based staff could work and hold meetings with potential supporters, as well as offering a space for service deliveiy. became abundantly clear. With the appointment of new members of staff, the charity had outgrown our office space and a new hotne was needed. In December, the Board agreed to move to new premises in Clyst St. Mary. and an Agreement for Lease Mes sisFned in the final quarter of the year, confirming the charity would move to the new location in June 2025. IsolAtRon Room Refurbishment Working with our pai'tnei-s in the NHS we have identified a need to niodernise and I'edecorate the isolatioii rooms on Yarty Ward. These are Single occupancy treatiMent rooims, typically used by patieiits who ar¢ receiving complex or aggressive treaiments. The rooms have been largely untouched siiice the ward opened in 2006 and are in i)eed of improveni¢n£. ELF agreed to fund the improvements, and have worked with the relevant teams in the NHS. including Yarty statT and the Estate5 team to develop a piDposal. By the end ot the financial year. an itemised list of prioriry work had been developed and initial drawings were coinpleted. Current Servlce Portfolio The services Exeter Leukaemia Fund currently offer in relation to the objectives ar¢ a5 follows.. Transport of patients to and from hospital Counselling to help patieiits and fainilies through the chall¥nges of the illness Financial support through our Patient Support Grant scheme Funds to purchase equipment to improve palieiit treatment and support Accornmodation near the hospital so families can be close to their loved ones Coinplemeiltary therapies for patients staying on Yarty Ward Free refreshments to patients ai)d relaiives awaitiiig Day Case appointments Financial advice througli our partiiership with the CAB Legal services throu￿7 our paitnei-shtp with Dlinn & Baker MAin Aetivities undertakeD to further the ChArlty's purposès for the public benellt: Service5 that ELF provided in 2024125 Transport ServS¢e The cl￿rity has three dedicated drivers talcing patients to and from their home to attend medical appointments at the Haematology Centre. fn 202415 the ELF transport team completed 2.202 passenger journeys, with a totsl distaiice of over 50.000. The increase on the previous year is accounted for by improved systems, as well as additional driver hours fi'om both paid and volunteer drivers. The chai'ity has three dedicated drivers taking patients to and from their home to attend medical appointments at the Haeinatology Centre. In 202415 the ELF transport team completed 2.20? passenger journeys, with a total distance of ovcr 50,000. T]ie increase on the previous year is accounted for by improved systems, as well as additional driver houis from both paid and volunteer drivers. This service 15 seen by external agencies and p￿tnerS as one of ELF'S Unique Selling Point (USP) services. Page 5

Exeter Leukaemia Fund CIO Trustees, Report (continued) CounselllDg Seryice We appointed a Counselling Setvices Lead to wn the counselling service, which continu¢s to grow. In ?0?4125 I I I patients were i'eferred to t]ie service. We also offered support to group work led by the NHS, and by ELF. AccommodAlion ELF offers financial support to p&tients requiring hotel stays in Exetei. due to their treatment plans. We are grateful to our partners at Mercure Southgate who offer a discounted rate for ELF patients. Filing Time The ELF kiosk, in the Haematology Centre reception, offers snacks and refreshments to patieiils aiid their supporters. A limited nutiiber of ileins, tncluding liot drinks, fruit, biscuits aiid crisps are offered free of Charge, though may usei's elecl to ott.er a donation. The café is run by a membei. of ELF staff, and suppoited by volunteers during periods of annual l¢av¢ or illness. Complementary Therapies Aroniaiherapy massage treatnient is provided for pafients stayin8 on Yaty Ward. During the year. the service offered 119 patient appoinimeiits. Cltizens Advice Service During the yeai.. ELF has continued to pi'ovide link5 to the Citizens Advice service foi. patients requiring their specific help. Across the year, 73 patients w¢r¢ seen. resultiiii? in over £600,000 worth of financial support. Legal Servlces ELF offers a free will setvice to patients, patients faiiiilies, volunteers and supporters through a partnership with local solicitors Dunn and Baker. The service iiicludes tlie wj'iting of a staiidard will aiid is completely fl'ee of ch8r¥e. The switch fi'om a previous national supplier offers a more localised personal seivi¢e with a local office. Income Generation Fundraising Exeter Leukaemio Fund is now entirely supported by voluntary donations and gifts in Wills. The charity's team of two full-time fuiidraisers iiicreased during the year, to increase income geiiei'ation potenlial. We welcomed a new Head of Iiidividual Giving in January 2025, whose I'emit is to focus on gifts from individual doiiors. We also appointed a Charity Lead Administrator to support administrative work and provide marketin&> support. Aci'oss the year we piloted several new initiatives to generate income, including a calendar featuring local sceiies suggested by patieiits, and a collaboratioii with a local musiL charity to put 01) an eveiiing of opera at a local stately liome. The tundraising team aimed to diversify iiicome and build on an iiiei-cased awareiiess of tlie charity's work, following a number of successful charity of the yfdr applications. Fundraisingi was supported by 108 voliinteers contributing 690 hours of support, covering a l'ange of roles Such as administt7tion, bucket collections and coordinating collection boxes. Twsts and tprants remain an area for growth. and we continued to develop case studies in support of poteiitial grant applications. We had a strong year for Lega¢y income, and received £149,820 from eight separate legacy donations, Page 6

Exeter Leukaemia Fund CIO Trustees, Report (continued) Retail Following the decision taken by the Board in ?0?3124 to ¢ease the charity's i'etail function, the remaining shop, ili Crcditon, ¢losed in June 2024. Review of activities Following a review of govemance. policy and procedure in 2023124, the staff and Trustees this year gave their attention to income generation, lo ensiire the financial sllstainability of the cliarity. This resulted in the appointinent of the Head of Individual Giving, and an increased focus on promoting legacy giving. The Board took the decision in December 2024 to uiidertake a review of the patient journey and ELF'S services. The agreed approach was to apply to work with the University of Exeter MBA prograinme. if possible. The timeline for this w02'k is to begin the review in June 2025, with a completion date in Septembei. 2025, The outlook is very positive as we continue to strengthen and improve. We look foiivard to working with staff. Trustees and partners to increase our service provisioi) to ensure the best possible outcomes for haematology patients 111 Devon. Flnanclal revlew Going concen) After Imaking appropriate enquiries, the Trustees have a reasonable expectation that rhe c.harity has adequate resourc¢s to continiie in operational existence for the foreseeable future. Foi. this reason. they continue to adopt the going concern basi5 in prepariiig the fiiiancial statements. Further details regarding the adoption of the going conceiii basis Can be found ili tl)e ac¢ountiiig policies. Reseives policy Tlie trustees, loiig-teriii strategy is to seek i'eserves excludin8 property to provide financial stability and the Ineans tor the development of oui. principal activities. We intend to maintain oui. reserves al a level which would allow an orderly wind down of the charity shoiild that ever need to be considei'ed. lft the coming year we also intend to use a portion of our rcseives to establish an investmeftt portfolio with the &ini of using iiiterest realised to contribute towards cliarity rui)ning ¢os15. We intend to use the reserves in the fol lowing manner: Financial sustainability of the chai'ity Establishment of an investrnenf portfolio Community and Hospital Service development As at the year-end, ELF has total fiinds available of £673,543 (2024: £645,658) and unrestricted funds of £6?6,979 {2024: £614,523). Structure) governance 3nd management Constitution Exeter Leukaemia Fujid is a registered cliarity, number 1154727, and is coiistitukd under a Charity Commission Scheme. The charity is governed by its CJO Deed, dat¢d l January 2014 which was amended 19 January 2021 and under this deed is constituted as a Charitable Incorporaied Org2ni5ation (CIO). The Trustees meet quarterly. Th¢ CJO deed stipulates that the Tntst¢es shall comprise iiot more than Leii, nor less than three persons. The CIO has power to do anything which is ealculaled to further its objects or is condueive or incidental to doing so. In particular. the CIO has power to.. Page 7

Exeter Leukaemia Fund CIO Trustees, Report (continued) l. borrow moiiey and to charge the whole or any part of its property as security for the repayment of the money borrowed. The CIO must cornply as appropriate with sections 124 and 125 of the Cl]ariÉies Act 2011, if it wishes Èo mortgage land: 2. buy, take on lease or in exchange. hire or otherwise acquire any property and to maintain and equip it for sell, lease or otherwise dispose of all or any part of the property belonging to the CIO. In exerGisiiig this power, the CIO must cornply as appropriaie with sections 117 and 119-123 of the Cliarities Acc 2011 ' 4. employ and remunerate such staff as are necessary for cairying out the work of the CIO. Th¢ CIO may eniploy or remunerate a charity trustee only to the extent that it is permitted to do so by clause 6 (Benefits and payinentS to charity trustees and connected persons) and provided it ¢omplies with the conditions of that clause; 5. deposit or invest funds. eniploy a protessioiial fijnd-manager, and arrange for the invescments or other pi'opety of the CIO to be lield in the name of a noininee, iii the S￿me nianner aiid subje¢t to the same conditions as the trustees of a trust &re permitted to do by the Triistee Act 2000. Membership of the CIO b. Methods of xppointment or eleetlon of Trustees The management of the Chariry is the responsibility of the Trustees who are elected and co-opted iindei. the ternis of the Chai'ity Commission Scheine. The Trustees al'e eligible. in comniittee, lo appoint additional trustees under the terms of the CIO constitution. Apart from the first chai'ity trustees. every Trustee may be appointed for a muimum term of thi'ee. three-year temis by a resolution passed at properly convened meetiiigs of the CIO Trustees. In selecting individuals for appointsnei)t as Trustees, Ilie existing Trustees must have regard to tlie skills, knowledge and experience needed for the effective administrmtioi) of the CIO. Policies adopted for the induction and trAlning of Trustees New li'ustee5 are selected based on the skills and exp¢i'ience, which should coinplemenc those of the existing Board of Trustees. They meet with existing Trustees and key Inembers of staff to ensure that they feel comfortable with the organisalion aiid liappy to bccome pai't of the tcain. The charity Trustees will make available to each new cliarity Trustee. on or before his or her first appointment: a) a copy of the current vei'sion of this constitution- aiid b) a copy of tlie CIO'S Latesl Trustees, Annual Report and stateinent of accounts. As with all staff.. "The Trustees ofELF review $8laries on an annuil basis, nomally December; however, there is no guarantee of an automatic increase in your pay as a result of any review Employee Handboul(. Plalls for future perlody The Ti'ustees will focu5 On the relationship with the RD & E. specifically Yarty Ward and the wider liaematology service inrluding that in North Devon, in order to provide lielp and support to patients iii the most meaningful way. This relationship is seen as paramount so that the haematology staff are supported by the charity and can therefore provide the best care for their patients and 50 that ELF can then provide support in additioii to this care. Page 8

Exeter Leukaemia Fund CIO Trustees, Report (continued) The Trustees will also encouiage charity staff to undeitske a review of patient services to ensure they are being managed effectively and are fit for pui'pose and ihe changing iieeds of the patients. Funds held xs custodia None The annu approved by the irus¢ee5 of the ch&rity on ..... and signed 011 its behalf by: V F. S Salom Chairman an ns stee Page 9

Exeter Leukaemia Fund CIO Statement of Trustees, Responsibilities The trustees are responsible for preparing the tnistees, report and the fiiianrial statements in accordance with the United Kingdom Accounting Standards (United Kingdom Generdlly Accepted Accountiiig Practiee) and applicable law and regulatioiis. The law applicable Èo charities requires the trustees to prepare ftnaneial statements for each financial yeai. which give a true and fair view of th¢ state of atTair5 of the chai-ity and of the iiicoming resoui'ces and application of r¢sour¢es of the charity for that period. Iii preparing these financial statements, the trustees are required to: select Suitable accounting polieics and then apply thein consistently. observe the methods and principles in the Charities SORP, make judgements and estimates that are reasonable and prudeiit- state whethei. applicable accounting standards have been followed. SLibject to any material departures disclosed and explained in the financial statements, and prepare the financial stateiY]ents on the going Concern basis uiiless it is inappropriate to presume that the chai'ity will ¢ontinu¢ in busiiic55, Tli¢ trustees are responsible for l<eeping proper accounting recoi'ds that disclose with reasonable a¢ouracy at any time the fiiiancial position of th¢ chai'ity and enable th¢in to ensui'e that the financial statement5 Comply with the Charities Act ?01 I, the Charities (Accounts and Reports) Regulations ?008. and the provision5 of the constitution. Tlie truslees are a150 responsible for safeguardiiig che assets of the charity aiid hence for taking reas01)able steps for the pi'evention and deiection of fraud and other iri'egularities. Tlie tiiistees are respon.sible for the maintenance and integi'ity of the corpoi'ate and financial iiiforini¢ tion included on the charitable coinpany's website. Legislation governing the prepai'ation and disseininalion of financial statements may differ from legislation in other juri5dicÉions. the trustees of the chai'ity on l...i• :.W.%-. and signed on its behalf by., VESSal Chairmaii and trustee Page 10

Exeter Leukaemia Fund CIO Illdependent Examiner's Report to the trustees of Exeter Leukaemia Fund CIO I report to the trustees on Iny examination of the aecounts of Exeter Leukacmia Fuiid CIO for the year ended 31 Mairh 2025. Responsibilities thnd basis of report As tl)¢ charity twstees of Exeter Leukaemia Fund CIO you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act ?0 I l {'the Act,). I report in respect of my examinatioii of the Exeter Leuk&emia Fund CIO'S accounts carried out under sectioi) 145 of the 201 l Act and in cai'rying oui my examination I have followed all the applicable Dii'ections given by the Charity Commission under section 145(5)(b) of the Act. Independent examiner'5 Statement Since Exeter Leukaemia Fund CIO'S gross intDme exceeded £250.000 your examiner must be A member of a body listed iii sectioi? 145 of the 201 l Act. I confiiTh tliat l am qualified to undertake the examination because I am a member of The Association of Chartei'ed Certifi¢d A¢roLintants, which is olle of the listed bodies. have completed my examinaiion. T confirm tliat no material inatters have come lo my attention in connection witli die eX￿nInatiOn giviiig me cause to believe t]iat in a11y niateri&l respect.. accounting I'ecords were T]Ot kept in rcspect of Exeter Leiikaemia Fund CIO as requii-ed by Section 130 of the Act,. or 2. the accounts do not accord with those records. or 3. the accounis do not comply with the accouiiting requirenients ¢oi)cemiiig the fom and content of accounts Set out in the Cliaritie5 (Accounts and Reports) Regulations 2008 other tlian any requireinent tliat tlie ccounts give a 'true and fair view, which is not a matter considei'ed as part of an independent exaininalion. I have no conccrns aiid have come across no other matters in connection with the exaniinalion to which attention should be drawn in tliis report in order to ei)able a proper understandii)g of tlie accounts to be reaclied. Dave Tucker FCCA Independent Examiner The Association of Cliartered Certified Accountants Thompson Jenner LLP Chartered Accouiltants I Colletoii Crescent Exeter D￿on EX2 4DG Date:..................... Pagell

Exeter Leukaemia Fund CIO Statement of Financial Activities for the Year Ended 31 March 2025 Uhrestricted funds ResÉriet funds Total 2025 Note IDeome and Endowments from: Donations and legacies Other tradiiig activities liivestment iiicome 413,514 47,501 9,580 27,583 441,097 47.501 9,580 Total income 470,595 27.583 498.178 Expenditure on: Raising ft]nds Charitable activities (169.711) 1?88.839) (169.711) (300.582) {11,743) Total expenditure Net income (458.550) (11,743) 470.293) 12.045 15.840 27,885 Net movement in funds 12.045 15.840 27.885 Reconciliation of fund8 Total funds brought forward 614.523 31,135 645.658 Total funds carried forward 19 626,568 46,975 673,543 The not¢s on pages 15 to 26 forni an inte(yral part of these financial slat¢ments. Page 12

Exeter Leukaemia Fund CIO Statement of Financial Activities for the Year Ended 31 March 2025 (continued) Unrestriettd fvllds Restricted funds Total 2024 Note Income and Endowments from: Donations and l¢gacies Other tradiiig activities Investment ii)¢ome 247,133 16?555 9,4?1 32.104 279,237 162,555 9.421 Total income 419.109 32,104 451.213 Expenditure on: Raisiiig. funds Charitable activities {250.527) 241,717) (250.527) 268.305 (26,5881 Total expe11diture 492,244 26,588) (518,832) Net (expenditure)/income 73.135 .5.516 67.619 Net mov¢m¢nt in ￿ndS (73,135) 5.516 (67.619) Reconciliation of funds Total funds brouglit foiward 687,658 25,619 713.277 Total funds cari'ied foiwai'd 19 614,523 31,135 645,658 All of the charity's activities derive from continuiiig operations duriii¥ (lie above two periods. Tlie ftinds breakdown for ?024 is shown in note 19. The notes on p&ges 15 to 26 fomi an inte￿.a1 part of these financial statements. Page 13

Exeter Leukaemia Fund CIO (Registration number: 1154727) Balance Sheet as at 31 March 2025 2025 2024 Note Fixed assets Tangible assets 13 11,730 17,924 Current assets Stocks Debtors Cash at bank and liand 14 1,954 24,150 659.258 2.627 16 6?5.77? 685.36? 670,874 Creditors: Amounts falling due witbin one year Net current assets 23,549 43.140 661,813 6?7.734 Net A55ets 673,543 64S,658 Funds of the chArlty: Resti'icted income thnds Restricted funds 19 46,975 31,135 Unrestricted income funds Uni'estricted funds 626,568 614,523 Total funds 19 673.543 645,658 The finaiicial statements on pages 12 10 26 were approved by the trustees, 8iid authorised for i&su¢ on IAJQ.,. d sigiied on their b¢half by: VESSal Chairman cn ee The notes on pages 15 to 26 forni an intetsral part of these financial statements. Page 14

Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2025 I Charsty status The chai'ity is a Chai'itable Incorporaied Organis&tion r¢gi5tered in England and Wales. Tjie addr¢ss ofits registered office is: Tlie ELF Office Haematology Centre Royal Devon & Exeter Hospital Exeter EX2 .SDW 2 Accounting policies Statement of eornpliAne¢ The financial stateinents have been pi'epared in accordance with Accounting and Reporting by Charities.. Stateiiient of Recoiniiieiided Pi'actice {applicable to charities pi'eparing tlieir accouiits iii accordance willi tli¢ Financial R¢portingF Standard applicable in the UK and Repiiblic of Ireland (FRS 102)) (issiied in October 2019) (Charities SORP (FRS I O?)}, the Fiiiaiirial Reportiii¥ Standard applicable in the UK aiid Republic of Ireland (FRS 102) and the Cliarilies Aci 2011. Basis of prepRrAtlon Exeter Leukaeniia Fund CIO nieets the definition of a piiblic benefit eiitity u11d¢r FRS 10? The accounts (fiiiancial stateinentsl have been pi'epared uiider Ilie historical cost convention witli items I'ecogni5ed at cost or tr8nsa¢tion value unless otherwise stated in the relevant note(s) to these accounts. Golng concern The ti'ustee5 coiisider that tliere are no material uncertaiiities about the charity's ability to Goiitinue as a going concern. Intome endowments Voluntary income includiiig donation5. gifts, leg&cies and ￿zntS that provide core funding or are of a general nature is recognised wlien the charity has eiititlement to the income, 11 is probable that the incorne will be received and the amount can be measured with 5ufficieiit reliability. Donttilons and legacies Donations al'e re¢o8nised when the charity has been notified in writing of both the aixount and settlement date. lii the event tliat a donotioii is subject to conditi0115 that require a level of performai)ce by the charity before tlie charity is entitled to tlie fui)ds, the income is deferred and not recognised ui)til either those conditions are fully met, or the fulfilment of those conditions is wholly within the Control Df tlie chariry and it is probable that these coiiditioijs will be fulfilled iii the reporting period. Legacy gifts are recognised on a case by case basis following the gi'ant of probate when the administt2torlexecutor for tlie estate has communicated in w-iting both the a]nount and settlement date. Jn the event tliat the gift is iii the form of at] asset other than cash or a financial asset traded on a recognised stock exchajige. recoJts ition is subject to the value of the gift beii)g reliably measurable with a degree of reasonable accuracy and th¢ title to the ass¢t having been transfei'red to th¢ chai'ity. Pag¢ 15

Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2025 (continued) Grants receivuble Grnnts ar¢ r¢cognised when th¢ charity has an entitlement to the fiinds and any ¢onditions linked to the grdnts have been met. Where performance conditions are attached to the grant and are yet to be met. th¢ income is recognised as a liability and included on the balAnce sheei as deferred iiicome to be released. Deferredinconie Deferred income represents amounts received foi. future periods and is released to incomiiig resources in the period for which, it ha5 been received. Such income is oiily deferred when: The donor specifies that the grant or dor]ation must only be used in future accounting periods; or The donor has imposed conditi01ls which niusl be met before the Chai'ity has uncoiidilional entitlement. Gifts iii kind Gifts in kiiid donated for distributioii are iiicluded at valuation aiid recogiii%ed as iiicome when they are disti'ibuled to the projects. Gifts doii&ted for resal¢ are in¥luded a5 income wheii they are sold. Gifl éild Iiicome tax recovei'able in relation to donations re¢eived under gift aid or deeds of covenant is recognised at the time of tlie doiiation. Jnveslmeiil inL'opne Interest oli fuiids held oli deposit is included when receivable and the amount can be nieasured reliably by the harity; tjiis is iioi'mally upoii notification nf the intei'esi paid or payable by the bank.Dividends are recognised once the dividend ha5 been declared and notification has been received of the dividend due. Expellditure All expenditui'e is recognised once there is a legal oi. consu￿¢tIve obligation to that expenditure, it is probable settlement is required aiid the amount can be measiii'ed reliably. All Costs are alloc&ied to the applicable expeiiditure lieading that agg71'egaÉe similar costs to that category. Whei'e costs cannot be directly atti'ibuted to particular h¢adiiig5 they have beeii allocated oli a basis Lonsisient witli tlie use of resources, witli ceiitral staft cost5 allocated on the basis of time Spent. and depi'e¢iation Charges allocated on the portion of the asset's Use. Other support costs are allocated based on the spread of staff costs. Raisiiigfiinds These are costs incurred in atti'acting voluntary inwme. the manageinent of investments and those incurred in trading activities that raise funds. Charitable llLtivilies Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs tliat can be allocated directly to such activities a]id thos¢ costs of an indirect i)atlli'e necessary io support them. SupporÉ costs Support costs include central functions and have been allocated to activity cost cat¢gories on a basis c017SiSteiit with tlie use of resources, for example. allocating property costs by floor areas. 01- per capita, staff costs by tl)e tinie spent and other costs by their usage. Page 16

Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2025 (continued) Gov¢i'nance costs These incllide the costs attribLltable to the charity's complianc¢ with constiiutional and statutory requirements. including audil. straiegic manageinent and trustee5 meetings ajid reimbursed expe115es. Txxation The charity is considered to pass the tests set out in Paragraph I Schedule 6 of the Finance Act ?010 and thei'efore it meets the definitioii of a charitable company for UK corporation tax purposes. Accordingly. the chai'ity is potentially exempt froin taxation in respect of income or capital gains I'eceived within categories overed by Chapter 3 Part I l of the Coi'poraiion Ttix Act 201 O or Section 256 of the Taxation of Chargeable Gains Act 1992. to the extent that siich inco1￿¢ or gain5 are applied exclusively to charitable purposes. Tangible fixed assets Individual fixed assets costing £ 100.00 or more are initially Itcorded at cost, less any subsequent accumulated depreciatioii aiid subsequeiit accumulated inipairmeiit losses Depreei#tioll and amortisxtion Depitciation is provided on tangible fixcd asset5 so as to wj'ite off the Cost or valuation, less any estimated residual value, over their expected usefvl eeoiiomic life as follows: Asset class Motor vehicles Fixtures and fittings Office equipment Depreeiation method And rate O % straight line 15 % straight linc 200/D and 33.330/0 slraight line Stock Stock is valued at the lower of cost and estimated selling price less costs to complete and sell, after due regard for obsolete and slow nioviiig stocks. Cosl 15 determiiied using the first-in, first-out (FIF O). Trade debtors Trade debtors are aniount5 due from customers for merchandise sold or services performed in che ordinary coui'se of business. Trade dcbtors are recognised iiiitially at the tr￿]sactIon price. They are subsequently measured at aJnortis¢d cost using tlie effective iiiterest method, less provision for impairment. A provision t.or Ilie impairmeni of trade debtors is established wlien there is objective evidence that the charity will not be abl¢ to rollect all amounts due according to tlie originMI teiThs of the receivables. Cash and cash equivBlents Cash ffnd c&sh equivalents compi'ise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertiblc to a known amount of cash and are subject to an insignificant i'isk of change in value. Page 17

Exeter Leukaemia Fund CIO Notes to the Flnancial Statements for the Year Ended 31 March 2025 (continued) Trmde Creditors Trade creditors are obligations to pay foi. goods oi. services thai have been a¢quii'ed in the ordinary course of busine55 from suppliers. Accounts payable are classified as current liabilities if the does not have an unconditional right, at tlie eiid of tlie i'eporting period, to defer settlement of the crediior for at least twelve months after tlie reporting date. If th¢r¢ is an unconditional right to defer settlement for at least twelve months after the reporting date, they al'e presented as non-current liabilities. Trade creditors are recogiii5ed initially at the transaction price and subsequently measured at amortised cost using the effective interest method. Fund strueÉure U11￿striCted incoiiie fjJi)ds are g¢n¢i'al fu17ds that are available for use at the trustees disci'etioii iii ftirthei'ance of the objectives of the charity. Restricted income funds are ihose donated for use in a particular area or for specific purpos¢s, the use of which is restricted to that area or purpose. Pensions And other post retirement obligations The charity operates a defiiied contribution pension scheme which is a pension plan under which fixed coiitribulioiis are paid into a pe115ioiI fuiid and the clidrity has no le¥al oi. constructive obligyatioii to pay ￿l'ther conti'ibutions even if the fund does llot hold Sufficient assets to pay all employees ¢lie beiiefits relating to employee service iii tlie ciirrent and prior periods. Contributions to defined coiitribulion plans are recognised in tlie Statement of Financial Activities when they are due. If contribution payments exceed the conti'ibiition due foi. service, cli¢ excess is recognised as a prepayment. FinaNcial instruments Tlie C.liarity oiily lias financial assets aiid financial l labilities of a kiiid tliut qualify as basic fiiiancial iiis(ruinei)s. Basic financial insti'iiments are initially re¢ogi)ised at transaction pi'ice and subseqLtently measured at theii. setilemeiit value with the exceptioii of bank loans which are subsequeiitly measui-ed at aitjortised c05t usinby the effective inierest metliod. Page 18

Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2025 (continued) 3 Income from donation5 and legaeies Unr¢strlcted funds GenerAI Resfjricted funds Total 2025 Total 2024 Donations and lega¢i¢g' Donations from compaiiies, trusts and similar proceeds Legacies Grants, including Capital grants- Grants from companies 251,564 149.820 27,583 279.147 149.820 234,818 25,519 12,130 12,130 18,900 413.514 441,097 279.237 Of the above income £413,514 (?024.' £247,133) was unresti'icted and £27,583 {2024.. £32.104) was restricted. 4 Ineome fyom other tradlng aetivities Unrestrlcted funds General Total funds Total 2024 Ti7ding income; Charity shops Other fijiidraising 12,475 35.026 12.475 35,026 129.320 33,235 47,501 47,501 162.555 S Investment incom¢ Unrestricted funds General Total 2025 Total 2024 Dividends I'cceivable froin otlier listed investmcnts Interest receivable on bank deposits 123 9.457 123 9,457 133 9,288 9,580 9,580 9,421 Page 19

0¢ ery Eo Q¢ - C tn 4 ry4 rn fn v) ￿ C

Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2025 (continued) Of totsl expenditure £11.743 {?024- £26.588) is restrickd and £458,550 (2024- £492,244) is unrestricted. 7 Analysis of governance and support costs Governance costs Unrestricted funds General TotAI 2025 Total 2024 Stsff costs Wages and salaries Social security costs Peiision COSLS Independent exaininer fees Examiiialion of the financial statements Other fees paid to examiiiers 26,366 2.820 667 26,366 37,159 3,787 913 667 1,000 2,200 1,000 2,200 1.000 2,000 33,053 33,053 44.859 8 Net incomingloutgoing r¢sour¢es Net incomingl(outgoing) resources for the year include,, 2025 2024 ProtiLI(loss) on disposal of tangible fixed assets Depreciation of fixed assets 60 6.575 147 6,998 9 Trustees remunerAtlon and expenses No trustee5. nor any persons coiinected with them, have received any itmuneratton from th¢ charity during the year. No trustees liave received aiiy reimbursed expenses or aiiy other benefits froin the charity during tlie year. Page 21

Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2025 (continued) 10 Staff costs The aggregate payroll costs weir as follows.. 2025 2024 Staff costs durillg the yearweye: Wages and Salaries Sorial 5ecui.ity costs Pension costs 242,873 16.400 5.153 274,464 5,096 264,426 295,632 The monthly average iiumber of persons (including senior managemciit / leadership team) eniployed by tlie harity dui'ing the year wms as follows: 2025 2024 A verage nuinber of employees 14 14 Coiitributions to the employee pension schemes for the year totalled £5,153 (2024 - £5.096). Th¢ total employee benefits of the key management personnel of the charity were £59,705 {2024- £83,718). No employee received emoliiinents of morc than £60,000 during the year I I Independent exJmin¢r's remuneratlon 2025 2024 Examination of the financial statements 1.000 1,000 Other fees to exAminers All other services 2,200 ,000 12 Taxation Tile charity is a registered charity and is therefore exempt from tsxation. Page 22

Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2025 (continued) 13 Tangible fixed assets Furniture and equÈpment Computer equipinent Motorvehicles Tot91 Cost At l Api-il 2024 Additions Disposals 4,482 11,973 23.165 420 (1,312) 39,620 420 1,312) At 31 March 2025 4,482 11,973 22,273 38,728 DepreciAtion At l April 2024 Charge for the year Eliminated on disposals 4,032 268 6.386 2.394 11,278 3,912 (1,272) 21,696 6,574 (1.272 At 31 Mai'cli 2025 4,300 8.780 13.918 26,998 Net book value At 31 March ?025 182 3,193 8,355 11.730 At 31 March 2024 450 5,587 11,887 17.924 14 Stock 202S 2024 Stocks 1.954 ?,627 15 Debtors 2025 2024 Trade debtor5 Prepaymeiits VAT recoverable Other debtors 1,026 11,663 2,491 8,970 4,093 8,465 27,352 24,150 42,475 16 Cash cash equivxlent5 2025 2024 Cash on hand Cash at bank 280 658.978 273 62S,499 659,258 625,772 Page 23

Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2025 {continued) 17 Creditoi's: amounts falling due within one ye4r 2025 2024 Trade Creditors Other creditors Acci'uals Deferred income 11,197 1,889 9,153 1.310 9.565 1,377 23,549 43,140 2025 2024 Rcsources defetTed in tiie period Deferred incoine at year end 1,310 1,310 18 Obligatlons under le4se$ and hli'e purehA5e cotttracts Operating leAse commitments Total ￿tUre minimum lease payinenls under non-cancellable operating leases are as tollows., 2025 2024 Other Withiii one year Between one and five years 16,983 ?.978 38,601 19.961 19.961 58,562 Page 24

Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2025 (continued) 19 Funds Balonce at I April 2024 Incoming resources Resoui'ces expended Balance at 31 MAreh 2025 Unrestrlcted fuDds General General funds 614,523 470.595 (458.550) 646,568 Restricted fuiids Chevithorne Family Suite Counselloi. Transport Hospital ftEnd Paticnt 5UPPOrt (coordinator) Fellowship Bi'ai)Ible Ward Haeinatolo&ry Total restricted funds 668 7,250 668 7.250 560 27,52 6,537 2,038 ?,000 400 1.000 23.388 (440) (8.508) (?,000) 8.537 2,038 2,000 1.195 795) 31,135 27.583 11.743) 46,975 Total funds 645,658 498,178 470,293) 673.543 Balaii¢e at I April 2023 liicoining resoui'ees Resoui'ces txpeiided BAl#nce at 31 MArch 2024 Unrestrlrted funds Geiieral G¢neral funds 687,658 419,109 (492.244) 614,523 Restricted Chevithorne Family Suite Counsellor Tran5POrt Hospital fund Patient SLlPPQrt (coordinator) Fellowsliip 668 668 7,250 10.250 1,000 16,729 1.000 3,125 (3.000) { 1,000) (5.917) (15,584) (1.087) 1,830 23.121 12,642 8,537 2,038 TotAI re5tritted fund 25.619 32.104 (26.588) 31.135 Total funds 713,?77 645,658 Page 25

Exeter Leukaemia Fund CIO Notes to the Flnancial Statements for the Year Ended 31 March 2025 (colltinued) The specific purposes for which the funds are to be &pplied are as follows- Chevithorne Family Suite The i'estricted funds represent amounts received foi- the Chevithorne project. The project is complete and tlie balwicc Ca￿led forward is to pay for the upkeep of the suite. There has not been any spend on this project in the year, Counselling - Grants received to cover counselling staffing costs. TransPOrt- Income ha5 been received in the period to help support the traiisport service. Patient Support Coordinator- This fuiid represents amounts raised froin a campaign that was run in order to fuiid the coordinator position. Hospltal fund This fund represents any income received which is restrieted to expeiiditure 011 Hospital suppoit. Bramble Ward-this fund5 restricted to smyths toy and tes¢0 vouchers for Bramble Ward. Haematology- this funds represent aimounts received foi. tlie Haematology spending. F¢llowship - This ￿nd represeiits any i17¢0me received which is resu-icted io the fellowship programme. 20 AnAlysis of net Issels b¢twetn funds Uni'estricted fuiids GenerAI Total fund5 at 31 MArch Resti'icled funds Tangible fixed assets Current assets Current liabilities 11,730 638.387 123,549 11.730 685.362 (23.549 46,975 Total net assets 626.568 46,975 673,543 Unrestrleted funds CTeneral Tot&1 funds kt 31 MAreh 2024 Restricted funds Tangible fixed assets Curi'ent assets Current liabilitie5 17,924 679,739 (43,140) 17,924 670,874 (43,140) 31,135 Total net assets 614,523 31,135 645,658 21 Related party transactlons There were no related party transactions in the year. Page 26